The expanding field of biological therapy relies heavily on recombinant growth factor technology, and a precise understanding of individual profiles is absolutely crucial for refining experimental design and therapeutic efficacy. Specifically, examining the characteristics of recombinant IL-1A, IL-1B, IL-2, and IL-3 highlights important differences